Back to company

ONCOMAL ApS: Financial statements 2022

CVR: 34580367

ONCOMAL ApS (CVR 34580367) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -229,703 and a net result of DKK -639,153 compared with DKK -628,272 the year before. Equity amounted to DKK 101,699,540. The solvency ratio was 87.9%.

Gross Profit
-229,703 kr.
Profit/Loss
-639,153 kr.
Equity
101,699,540 kr.
Total Assets
115,686,343 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--230 t.-639 t.101.7 mio.-
2021--321 t.-628 t.65.1 mio.-
2020--39 t.-216 t.65.8 mio.-
2019--35 t.-201 t.66 mio.-
2018--344 t.-445 t.66.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ONCOMAL ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

ONCOMAL ApS: The 2021 annual report is outApr 8, 2022

ONCOMAL ApS has published its annual report for 2021. Gross profit came to DKK -320,739, and the net result was DKK -628,272.

Josef Rainer joins the board of ONCOMAL ApSApr 1, 2022

As of April 1, 2022, Josef Rainer has joined the board of directors of ONCOMAL ApS.

About ONCOMAL ApS

ONCOMAL ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thor Grundtvig Theander, Ali El-Salanti and Mads Daugaard. The company's owners include Thor Grundtvig Theander, Ali El-Salanti and Mads Daugaard. In 2025, the company reported a gross profit of DKK -515,532 and a net result of DKK -1,882,091 compared with DKK -1,216,243 the year before. Equity amounted to DKK 232,154,411.